Screening for Druggable RNA Targets Opens Door to Drug Development - Genetic Engineering & Biotechnology News

An unbiased screening strategy identified small molecules that bind the noncoding RNA prototype Xist, opening a new era in drug development.

There is enormous potential in the large, noncoding transcriptome to encode disease variants. This makes RNAs appealing targets for drug discovery. Although early prospects did not have good drug-lik… [+3737 chars]

full article...